AJR Am J Roentgenol

1. PANIGRAHI B
   Editorial Comment: Utilization of Radiomics to Identify HER2-Low Breast Cancer.
   AJR Am J Roentgenol. 2024 Feb 14. doi: 10.2214/AJR.24.30953.
   

   >> Share

   
   

   
   Ann Surg Oncol

2. CORTINA CS, Lloren JI, Rogers C, Johnson MK, et al
   ASO Visual Abstract: Does Neoadjuvant Chemotherapy in Clinical T1-T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery?
   Ann Surg Oncol. 2024 Feb 15. doi: 10.1245/s10434-024-15037.
   

   >> Share

   
   
3. SCHWARTZ T
   At the Speed of SOUND: The Pace of Change for Axillary Management in Breast Cancer.
   Ann Surg Oncol. 2024 Feb 12. doi: 10.1245/s10434-024-15010.
   

   >> Share

   
   
4. CHUNG AP, Dang CM, Karlan SR, Amersi FF, et al
   A Prospective Study of Sentinel Node Biopsy Omission in Women Age >/= 65 Years with ER+ Breast Cancer.
   Ann Surg Oncol. 2024 Feb 12. doi: 10.1245/s10434-024-15000.
   

   >> Share

   
   
5. CORTINA CS, Rogers CC, Teshome M
   ASO Author Reflections: Neoadjuvant Systemic Therapy and Nodal Management in cT1-2 N0 Triple-Negative Breast Cancer.
   Ann Surg Oncol. 2024 Feb 10. doi: 10.1245/s10434-024-15020.
   

   >> Share

   
   

   
   BMC Cancer

6. SU MX, Lin HW, Nguyen HTH, Lin TC, et al
   Monitoring trends in the absolute lymphocyte count and the neutrophil-to-lymphocyte ratio in patients with breast cancer receiving eribulin.
   BMC Cancer. 2024;24:195.
   

   >> Share

   
   
7. LABEDZ N, Anisiewicz A, Stachowicz-Suhs M, Banach J, et al
   Dual effect of vitamin D(3) on breast cancer-associated fibroblasts.
   BMC Cancer. 2024;24:209.
   

   >> Share

   
   
8. ZHANG Y, Song M, Yang Z, Huang X, et al
   Healthy lifestyles, systemic inflammation and breast cancer risk: a mediation analysis.
   BMC Cancer. 2024;24:208.
   

   >> Share

   
   
9. HUANG X, Yu Y, Luo S, Fu W, et al
   Correction: The value of oral selective estrogen receptor degraders in patients with HR-positive, HER2-negative advanced breast cancer after progression on >/= 1 line of endocrine therapy: systematic review and meta-analysis.
   BMC Cancer. 2024;24:205.
   

   >> Share

   
   

   
   Br J Cancer

10. SONG X, Fang C, Dai Y, Sun Y, et al
    Cyclin-dependent kinase 7 (CDK7) inhibitors as a novel therapeutic strategy for different molecular types of breast cancer.
    Br J Cancer. 2024 Feb 14. doi: 10.1038/s41416-024-02589.
    

    >> Share

    
    
11. YE HS, Zhou D, Li H, Lv J, et al
    Organoid forming potential as complementary parameter for accurate evaluation of breast cancer neoadjuvant therapeutic efficacy.
    Br J Cancer. 2024 Feb 10. doi: 10.1038/s41416-024-02595.
    

    >> Share

    
    

    
    Breast Cancer

12. HACKING SM, Windsor G, Cooper R, Jiao Z, et al
    A novel approach correlating pathologic complete response with digital pathology and radiomics in triple-negative breast cancer.
    Breast Cancer. 2024 Feb 13. doi: 10.1007/s12282-024-01544.
    

    >> Share

    
    
13. SATO K, Fuchikami H, Takeda N, Natsume N, et al
    Preliminary report on ultrashort perioperative partial-breast irradiation with multicatheter interstitial brachytherapy for early-stage breast cancer.
    Breast Cancer. 2024 Feb 15. doi: 10.1007/s12282-024-01546.
    

    >> Share

    
    

    
    Breast Cancer Res

14. WANG M, Du S, Gao S, Zhao R, et al
    MRI-based tumor shrinkage patterns after early neoadjuvant therapy in breast cancer: correlation with molecular subtypes and pathological response after therapy.
    Breast Cancer Res. 2024;26:26.
    

    >> Share

    
    
15. LI JK, Jin ZY, Xu YJ, Fu NQ, et al
    Contrast-enhanced ultrasound to predict malignant upgrading of atypical ductal hyperplasia.
    Breast Cancer Res. 2024;26:27.
    

    >> Share

    
    

    
    Breast Cancer Res Treat

16. MUTAI R, Kuchuk I, Goldshtein A, Yerushalmi R, et al
    The impact of germline BRCA pathogenic variants in locally advanced, triple negative breast cancer treated with platinum-based neoadjuvant chemotherapy.
    Breast Cancer Res Treat. 2024 Feb 12. doi: 10.1007/s10549-024-07247.
    

    >> Share

    
    
17. GUPTA S, Sinha Gupta S, De A, Banerjee R, et al
    Socio-cultural and financial issues against breast cancer screening behaviour among eligible Indian women: evidence for action.
    Breast Cancer Res Treat. 2024 Feb 12. doi: 10.1007/s10549-024-07244.
    

    >> Share

    
    
18. GAO L, Medford A, Spring L, Bar Y, et al
    Searching for the "Holy Grail" of breast cancer recurrence risk: a narrative review of the hunt for a better biomarker and the promise of circulating tumor DNA (ctDNA).
    Breast Cancer Res Treat. 2024 Feb 15. doi: 10.1007/s10549-024-07253.
    

    >> Share

    
    

    
    Cancer

19. LI X, Luo S, Fu W, Huang M, et al
    Discovery of a proliferation essential gene signature and actin-like 6A as potential biomarkers for predicting prognosis and neoadjuvant chemotherapy response in triple-positive breast cancer.
    Cancer. 2024 Feb 15. doi: 10.1002/cncr.35228.
    

    >> Share

    
    

    
    Cancer Epidemiol Biomarkers Prev

20. UONG SP, Torres JM, Alexeeff SE, Morey BN, et al
    Differences in Smoking Behavior by Nativity, Race/Ethnicity, and Education Among Women Diagnosed with Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2024.
    

    >> Share

    
    
21. ANDERSEN HH, Bojesen SE, Johansen JS, Ejlertsen B, et al
    Prognostic Value of Pre-treatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2024.
    

    >> Share

    
    

    
    Cancer Lett

22. XIONG H, Zhai Y, Meng Y, Wu Z, et al
    Acidosis activates breast cancer ferroptosis through ZFAND5/SLC3A2 signaling axis and elicits M1 macrophage polarization.
    Cancer Lett. 2024 Feb 13:216732. doi: 10.1016/j.canlet.2024.216732.
    

    >> Share

    
    

    
    Cancer Res

23. YAN L, Wu M, Wang T, Yuan H, et al
    Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming that Drives Immune Evasion.
    Cancer Res. 2024 Feb 9. doi: 10.1158/0008-5472.CAN-23-2390.
    

    >> Share

    
    

    
    Clin Breast Cancer

24. ZHANG C, Wang J, Wang H, Li J, et al
    Interference of the Circular RNA Sperm Antigen With Calponin Homology and Coiled-Coil Domains 1 Suppresses Growth and Promotes Apoptosis of Breast Cancer Cells Partially Through Targeting miR-1236-3p/Chromobox 8 Pathway.
    Clin Breast Cancer. 2023 Dec 2:S1526-8209(23)00304.
    

    >> Share

    
    
25. KESKINKILIC M, Sacks R
    Antibody-Drug Conjugates in Triple Negative Breast Cancer.
    Clin Breast Cancer. 2024 Jan 20:S1526-8209(24)00008.
    

    >> Share

    
    
26. MOKBEL K
    Elucidating Axillary Soft Tissue Involvement in Breast Cancer: Unveiling Metastatic Mechanisms and Therapeutic Perspectives.
    Clin Breast Cancer. 2024 Jan 29:S1526-8209(24)00024.
    

    >> Share

    
    

    
    Clin Cancer Res

27. BARTLETT JMS, Xu K, Wong J, Pond G, et al
    Validation of the prognostic performance of Breast Cancer Index (BCI) in hormone receptor-positive (HR+) postmenopausal breast cancer patients in the TEAM trial.
    Clin Cancer Res. 2024 Feb 12. doi: 10.1158/1078-0432.CCR-23-2436.
    

    >> Share

    
    

    
    Discov Oncol

28. LI F, Yang Y, Zhang X, Yu J, et al
    A novel prognostic model of breast cancer based on cuproptosis-related lncRNAs.
    Discov Oncol. 2024;15:35.
    

    >> Share

    
    

    
    Eur Radiol

29. PARTRIDGE GJW, Taib AG, Phillips P, James JJ, et al
    Take a break: should breaks be enforced during digital breast tomosynthesis reading sessions?
    Eur Radiol. 2024;34:1388-1398.
    

    >> Share

    
    
30. WANG Q, Lin Y, Ding C, Guan W, et al
    Multi-modality radiomics model predicts axillary lymph node metastasis of breast cancer using MRI and mammography.
    Eur Radiol. 2024 Feb 10. doi: 10.1007/s00330-024-10638.
    

    >> Share

    
    
31. ZHENG S, Yang Z, Du G, Zhang Y, et al
    Discrimination between HER2-overexpressing, -low-expressing, and -zero-expressing statuses in breast cancer using multiparametric MRI-based radiomics.
    Eur Radiol. 2024 Feb 16. doi: 10.1007/s00330-024-10641.
    

    >> Share

    
    

    
    Exp Cell Res

32. LI Y, Wei D, Chen Z, Chen Y, et al
    RBM10 regulates the tumorigenic potential of human cancer cells by modulating PPM1B and YBX1 activities.
    Exp Cell Res. 2024;435:113932.
    

    >> Share

    
    
33. XU W, Goreczny GJ, Forsythe I, Brennan G, et al
    Hic-5 regulates extracellular matrix-associated gene expression and cytokine secretion in cancer associated fibroblasts.
    Exp Cell Res. 2024;435:113930.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

34. YASHAYAEVA A, Dahn H, Svatos M, Zhan K, et al
    A Prospective Study Demonstrating Early Prediction of Skin Toxicity From Radiation Therapy Using Radiomic Features From Optical and Infrared Images.
    Int J Radiat Oncol Biol Phys. 2024;118:839-852.
    

    >> Share

    
    

    
    J Clin Oncol

35. MCGRADY ME, Willard VW, Williams AM, Brinkman TM, et al
    Psychological Outcomes in Adolescent and Young Adult Cancer Survivors.
    J Clin Oncol. 2024;42:707-716.
    

    >> Share

    
    
36. GEYER CE JR, Blum JL, Yothers G, Asmar L, et al
    Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]).
    J Clin Oncol. 2024 Feb 9:JCO2301428. doi: 10.1200/JCO.23.01428.
    

    >> Share

    
    
37. NEPPELENBROEK SIM, Geurts YM, Aleman BMP, Lugtenburg PJ, et al
    Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma.
    J Clin Oncol. 2024 Feb 15:JCO2301386. doi: 10.1200/JCO.23.01386.
    

    >> Share

    
    
38. CHEN JC, Elsaid MI, Handley D, Plascak JJ, et al
    Association Between Neighborhood Opportunity, Allostatic Load, and All-Cause Mortality in Patients With Breast Cancer.
    J Clin Oncol. 2024 Feb 16:JCO2300907. doi: 10.1200/JCO.23.00907.
    

    >> Share

    
    

    
    J Natl Cancer Inst

39. KERLIKOWSKE K, Zhu W, Su YR, Sprague BL, et al
    Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density.
    J Natl Cancer Inst. 2024;116:249-257.
    

    >> Share

    
    

    
    Lancet Oncol

40. PALMIERI C, Linden H, Birrell SN, Wheelwright S, et al
    Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multin
    Lancet Oncol. 2024 Feb 8:S1470-2045(24)00004.
    

    >> Share

    
    
41. CHEN N, Nanda R
    Androgen receptor agonism in advanced oestrogen receptor-positive breast cancer.
    Lancet Oncol. 2024 Feb 8:S1470-2045(24)00080.
    

    >> Share

    
    

    
    Nature

42. ANDRE F, Rassy E, Marabelle A, Michiels S, et al
    Forget lung, breast or prostate cancer: why tumour naming needs to change.
    Nature. 2024;626:26-29.
    

    >> Share

    
    

    
    Oncogene

43. VENTURUTTI L, Romero LV, Urtreger AJ, Chervo MF, et al
    Correction: Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis.
    Oncogene. 2024 Feb 14. doi: 10.1038/s41388-024-02961.
    

    >> Share

    
    

    
    Pathology

44. BAEZ-NAVARRO X, van Bockstal MR, Jager A, van Deurzen CHM, et al
    HER2-low breast cancer and response to neoadjuvant chemotherapy: a population-based cohort study.
    Pathology. 2024 Jan 18:S0031-3025(24)00007-2. doi: 10.1016/j.pathol.2023.
    

    >> Share

    
    

    
    PLoS Med

45. SELLEM L, Srour B, Javaux G, Chazelas E, et al
    Food additive emulsifiers and cancer risk: Results from the French prospective NutriNet-Sante cohort.
    PLoS Med. 2024;21:e1004338.
    

    >> Share

    
    

    
    PLoS One

46. PUVVULA PK, Moon AM
    Discovery and characterization of anti-cancer peptides from a random peptide library.
    PLoS One. 2024;19:e0293072.
    

    >> Share

    
    
47. RAGHURAM GV, Pal K, Sriram G, Khan A, et al
    Therapeutic interventions on human breast cancer xenografts promote systemic dissemination of oncogenes.
    PLoS One. 2024;19:e0298042.
    

    >> Share

    
    
48. SVENDSEN SMS, Pedersen DC, Jensen BW, Aarestrup J, et al
    Early life body size and puberty markers as predictors of breast cancer risk later in life: A neural network analysis.
    PLoS One. 2024;19:e0296835.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

49. ZIKRY TM, Wolff SC, Ranek JS, Davis HM, et al
    Cell cycle plasticity underlies fractional resistance to palbociclib in ER+/HER2- breast tumor cells.
    Proc Natl Acad Sci U S A. 2024;121:e2309261121.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share